BIOTIN

BIOTIN was reported 31546 times

BIOTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 120 0.6704
1 ANTACID THERAPY 55 0.4231
2 SLEEP DISORDER THERAPY 79 0.3990
3 APPENDICOLITH 101 0.2610
4 ANALGESIC THERAPY 80 0.2492
5 DRUG THERAPY 77 0.2271
6 CONGENITAL HIATUS HERNIA 50 0.2193
7 PRESBYACUSIS 64 0.2078
8 ANTICOAGULANT THERAPY 55 0.1937
9 MALIGNANT MELANOMA STAGE 0 39 0.1866
10 BACTEROIDES INFECTION 26 0.0996
11 PLEURAL THICKENING 66 0.0965
12 GAIT SPASTIC 32 0.0933
13 OBSTRUCTIVE SLEEP APNOEA SYNDROME 121 0.0829
14 MYOGLOBIN BLOOD INCREASED 121 0.0791
15 BLOOD MAGNESIUM INCREASED 66 0.0732
16 PLEURAL FIBROSIS 66 0.0648
17 NEEDLE FATIGUE 29 0.0635
18 HYPERPHOSPHATAEMIA 102 0.0474
19 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 43 0.0464
20 RELAPSING-REMITTING MULTIPLE SCLEROSIS 39 0.0451
21 BRAIN NATRIURETIC PEPTIDE INCREASED 123 0.0399
22 PLANTAR FASCIITIS 130 0.0387
23 BONE CYST 33 0.0352
24 BLOOD PHOSPHORUS INCREASED 91 0.0333
25 WRONG PATIENT RECEIVED MEDICATION 84 0.0307
26 TOTAL LUNG CAPACITY DECREASED 48 0.0300
27 PERIORBITAL PAIN 22 0.0260
28 TRICHORRHEXIS 70 0.0251
29 OSTEOSCLEROSIS 37 0.0235
30 DEAFNESS NEUROSENSORY 77 0.0234
31 INFUSION SITE DISCHARGE 40 0.0228
32 EYELID PAIN 43 0.0211
33 HYPERTONIC BLADDER 58 0.0201
34 EXOSTOSIS 176 0.0193
35 ONYCHOCLASIS 132 0.0192
36 HAIR GROWTH ABNORMAL 128 0.0185
37 EPIGASTRIC DISCOMFORT 72 0.0184
38 IRON DEFICIENCY 82 0.0182
39 BLOOD URIC ACID INCREASED 103 0.0178
40 PRE-EXISTING CONDITION IMPROVED 107 0.0171
41 LUNG OPACITY 45 0.0171
42 INFUSION SITE HAEMORRHAGE 56 0.0170
43 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 85 0.0168
44 AORTIC STENOSIS 58 0.0166
45 MONOPARESIS 29 0.0160
46 PLEURITIC PAIN 44 0.0159
47 SENSATION OF FOREIGN BODY 133 0.0158
48 MYASTHENIA GRAVIS 125 0.0155
49 HAIR TEXTURE ABNORMAL 206 0.0154
50 ESSENTIAL HYPERTENSION 28 0.0153
51 HYPOPHOSPHATAEMIA 110 0.0149
52 RESPIRATORY SYMPTOM 41 0.0144
53 DANDRUFF 31 0.0140
54 HYPERPARATHYROIDISM SECONDARY 34 0.0136
55 INCREASED UPPER AIRWAY SECRETION 69 0.0134
56 OBSTRUCTIVE AIRWAYS DISORDER 147 0.0132
57 BLOOD PRESSURE DIASTOLIC ABNORMAL 32 0.0126
58 BLOOD CALCIUM INCREASED 106 0.0121
59 MICTURITION URGENCY 136 0.0119
60 APPENDICITIS 111 0.0119
61 SECRETION DISCHARGE 148 0.0118
62 NEPHROGENIC ANAEMIA 54 0.0116
63 SEASONAL ALLERGY 163 0.0115
64 ALOPECIA 2256 0.0115
65 VITAMIN B12 DEFICIENCY 46 0.0113
66 SPONDYLITIS 41 0.0113
67 INFUSION SITE PRURITUS 35 0.0111
68 TROPONIN INCREASED 83 0.0109
69 NAIL DISORDER 94 0.0107
70 TRIGGER FINGER 42 0.0103
71 CARBOHYDRATE ANTIGEN 125 INCREASED 35 0.0103
72 MULTIPLE ALLERGIES 80 0.0102
73 INFUSION SITE BRUISING 22 0.0102
74 INGROWING NAIL 24 0.0101
75 SKIN WRINKLING 27 0.0099
76 BREATH SOUNDS ABNORMAL 48 0.0097
77 PRODUCT ADMINISTRATION INTERRUPTED 76 0.0097
78 FOREIGN BODY IN THROAT 30 0.0095
79 DECREASED INTEREST 56 0.0095
80 INFUSION SITE SWELLING 59 0.0094
81 VENTRICULAR FIBRILLATION 104 0.0094
82 VITAMIN D DEFICIENCY 91 0.0093
83 HYPERLIPIDAEMIA 111 0.0093
84 DEVICE INFUSION ISSUE 23 0.0093
85 LUMBAR SPINAL STENOSIS 27 0.0092
86 OSTEOPENIA 140 0.0092
87 SPINAL STENOSIS 38 0.0092
88 NEURALGIA 222 0.0091
89 BLOOD PRESSURE SYSTOLIC ABNORMAL 22 0.0089
90 HAIR COLOUR CHANGES 109 0.0088
91 TEMPOROMANDIBULAR JOINT SYNDROME 23 0.0086
92 DRUG ADMINISTERED AT INAPPROPRIATE SITE 90 0.0085
93 UPPER-AIRWAY COUGH SYNDROME 70 0.0085
94 PRODUCT FORMULATION ISSUE 56 0.0085
95 REGURGITATION 29 0.0084
96 BENIGN PROSTATIC HYPERPLASIA 43 0.0083
97 REBOUND ACID HYPERSECRETION 25 0.0083
98 HAIR DISORDER 68 0.0082
99 CYST 102 0.0082
100 BLOOD TEST ABNORMAL 115 0.0082
101 PERONEAL NERVE PALSY 46 0.0081
102 SPINAL OSTEOARTHRITIS 71 0.0081
103 PNEUMOTHORAX 127 0.0080
104 BACTERIAL INFECTION 149 0.0080
105 INFUSION SITE ERYTHEMA 67 0.0079
106 FINE MOTOR SKILL DYSFUNCTION 23 0.0079
107 ROSACEA 37 0.0079
108 INCREASED TENDENCY TO BRUISE 71 0.0077
109 SNORING 29 0.0077
110 ULCER 122 0.0077
111 ONYCHOMYCOSIS 33 0.0075
112 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 128 0.0075
113 GOUT 133 0.0074
114 CLUMSINESS 20 0.0073
115 MENISCUS INJURY 45 0.0073
116 CARDIOGENIC SHOCK 105 0.0073
117 FULL BLOOD COUNT ABNORMAL 77 0.0073
118 END STAGE RENAL DISEASE 132 0.0072
119 LIGAMENT SPRAIN 71 0.0072
120 SLEEP APNOEA SYNDROME 137 0.0072
121 ONYCHOMADESIS 30 0.0071
122 VITAMIN D DECREASED 61 0.0071
123 EOSINOPHILIA 125 0.0071
124 PARANASAL SINUS DISCOMFORT 27 0.0071
125 CONCUSSION 55 0.0071
126 DYSPNOEA EXERTIONAL 263 0.0070
127 OSTEOARTHRITIS 292 0.0069
128 NASAL DRYNESS 43 0.0069
129 BODY HEIGHT DECREASED 73 0.0068
130 THYROID MASS 26 0.0068
131 INFUSION SITE PAIN 87 0.0067
132 BLOOD BLISTER 21 0.0067
133 JOINT INJURY 143 0.0067
134 NOCTURIA 81 0.0067
135 EYE PAIN 374 0.0066
136 AUTOIMMUNE THYROIDITIS 25 0.0066
137 BLOOD THYROID STIMULATING HORMONE DECREASED 30 0.0066
138 URINE ABNORMALITY 30 0.0066
139 BLOOD POTASSIUM INCREASED 107 0.0066
140 HANGOVER 23 0.0065
141 DRY EYE 326 0.0065
142 SYNOVIAL CYST 30 0.0065
143 HYPERKERATOSIS 35 0.0063
144 ROTATOR CUFF SYNDROME 81 0.0063
145 BLOOD CHOLESTEROL ABNORMAL 29 0.0063
146 FOREIGN BODY SENSATION IN EYES 40 0.0063
147 THYROID FUNCTION TEST ABNORMAL 26 0.0063
148 RED CELL DISTRIBUTION WIDTH INCREASED 26 0.0063
149 HORDEOLUM 27 0.0062
150 HYPERCHOLESTEROLAEMIA 60 0.0062
151 ARTHROPOD BITE 46 0.0062
152 EYE INFECTION 70 0.0062
153 FUNGAL SKIN INFECTION 25 0.0062
154 BLADDER DISORDER 61 0.0061
155 SKIN ABRASION 29 0.0061
156 CHRONIC SINUSITIS 23 0.0061
157 VULVOVAGINAL DISCOMFORT 27 0.0061
158 DYSPHONIA 357 0.0061
159 BLOOD IRON DECREASED 72 0.0061
160 WALKING AID USER 40 0.0061
161 FOOT OPERATION 30 0.0061
162 CENTRAL NERVOUS SYSTEM LESION 83 0.0060
163 CORONARY ARTERY DISEASE 182 0.0060
164 CARPAL TUNNEL SYNDROME 84 0.0060
165 FOOD POISONING 32 0.0060
166 SINUSITIS 612 0.0060
167 HORMONE LEVEL ABNORMAL 29 0.0059
168 UPPER RESPIRATORY TRACT INFECTION 272 0.0059
169 SKIN LACERATION 64 0.0059
170 NAIL DISCOLOURATION 23 0.0058
171 BLOOD PRESSURE DIASTOLIC INCREASED 27 0.0058
172 VARICOSE VEIN 30 0.0058
173 SINUS DISORDER 115 0.0058
174 PHOTOPHOBIA 109 0.0058
175 MUSCLE SPASTICITY 71 0.0058
176 HYPERPHAGIA 23 0.0058
177 SKIN PAPILLOMA 23 0.0057
178 SWELLING OF EYELID 36 0.0057
179 INTERVERTEBRAL DISC DEGENERATION 53 0.0057
180 BALANCE DISORDER 495 0.0057
181 LYMPHOCYTE COUNT DECREASED 101 0.0057
182 EAR PAIN 110 0.0057
183 DRY MOUTH 459 0.0057
184 SCIATICA 90 0.0056
185 DERMATITIS CONTACT 64 0.0056
186 ANAL INCONTINENCE 50 0.0056
187 MUSCLE STRAIN 48 0.0055
188 TEMPERATURE INTOLERANCE 57 0.0055
189 OCULAR DISCOMFORT 62 0.0055
190 LIMB DISCOMFORT 169 0.0055
191 SLEEP DISORDER 385 0.0054
192 HIATUS HERNIA 70 0.0054
193 BLOOD CHOLESTEROL INCREASED 250 0.0054
194 VULVOVAGINAL PRURITUS 27 0.0053
195 INTERVERTEBRAL DISC PROTRUSION 115 0.0053
196 THYROID DISORDER 81 0.0052
197 ENERGY INCREASED 31 0.0052
198 MELANOCYTIC NAEVUS 23 0.0052
199 VULVOVAGINAL BURNING SENSATION 32 0.0052
200 TRIGEMINAL NEURALGIA 21 0.0052
201 CLAVICLE FRACTURE 20 0.0052
202 BLOOD MAGNESIUM DECREASED 45 0.0052
203 GASTROOESOPHAGEAL REFLUX DISEASE 419 0.0052
204 BRONCHIECTASIS 35 0.0052
205 MULTIPLE SCLEROSIS 248 0.0052
206 RHINITIS ALLERGIC 23 0.0052
207 FEELING OF BODY TEMPERATURE CHANGE 30 0.0051
208 ASPIRATION 56 0.0051
209 SINUS CONGESTION 69 0.0051
210 APPLICATION SITE EXFOLIATION 21 0.0051
211 NERVE COMPRESSION 47 0.0051
212 INITIAL INSOMNIA 52 0.0051
213 ORAL PAIN 113 0.0050
214 EXPOSURE VIA BREAST MILK 20 0.0050
215 BLOOD COUNT ABNORMAL 76 0.0050
216 LIMB OPERATION 24 0.0050
217 CEREBRAL DISORDER 37 0.0050
218 BRAIN FOG 78 0.0050
219 ATAXIA 59 0.0050
220 INSURANCE ISSUE 76 0.0050
221 MULTIPLE ORGAN DYSFUNCTION SYNDROME 140 0.0049
222 MULTIPLE SCLEROSIS RELAPSE 338 0.0049
223 INTERVERTEBRAL DISC DISORDER 21 0.0049
224 ASTHENOPIA 27 0.0049
225 MADAROSIS 57 0.0049
226 MUSCULOSKELETAL CHEST PAIN 76 0.0049
227 CONTUSION 471 0.0049
228 VAGINAL INFECTION 23 0.0049
229 SPINAL COLUMN STENOSIS 23 0.0049
230 FIBROMYALGIA 118 0.0048
231 SPUTUM DISCOLOURED 46 0.0048
232 FEELING DRUNK 36 0.0048
233 ABDOMINAL DISTENSION 505 0.0048
234 ABDOMINAL HERNIA 22 0.0048
235 MUSCLE SPASMS 875 0.0048
236 FULL BLOOD COUNT DECREASED 96 0.0048
237 GASTROENTERITIS VIRAL 86 0.0048
238 ASCITES 140 0.0048
239 OROPHARYNGEAL DISCOMFORT 43 0.0048
240 CONSTIPATION 1038 0.0048
241 TENDON PAIN 36 0.0047
242 LIGAMENT RUPTURE 21 0.0047
243 SOMNAMBULISM 31 0.0047
244 SINUS HEADACHE 28 0.0047
245 NECK PAIN 263 0.0047
246 TENDERNESS 49 0.0047
247 SKIN ATROPHY 27 0.0047
248 HEAD DISCOMFORT 83 0.0047
249 WEIGHT FLUCTUATION 49 0.0047
250 SCOLIOSIS 29 0.0047
251 THERAPEUTIC RESPONSE UNEXPECTED 210 0.0047
252 VITREOUS FLOATERS 46 0.0047
253 CYSTITIS 148 0.0046
254 SCAB 53 0.0046
255 SQUAMOUS CELL CARCINOMA OF SKIN 28 0.0046
256 VIRAL UPPER RESPIRATORY TRACT INFECTION 22 0.0046
257 MIDDLE INSOMNIA 86 0.0046
258 FLATULENCE 261 0.0046
259 SKIN LESION 126 0.0046
260 PULMONARY MASS 68 0.0046
261 POLLAKIURIA 190 0.0046
262 BRONCHOSPASM 65 0.0046
263 GROIN PAIN 40 0.0046
264 HOT FLUSH 343 0.0045
265 URINARY TRACT INFECTION 773 0.0045
266 ARTHRITIS INFECTIVE 21 0.0045
267 EYE DISCHARGE 47 0.0045
268 RED BLOOD CELL COUNT DECREASED 129 0.0045
269 FOOT DEFORMITY 50 0.0045
270 ERUCTATION 87 0.0045
271 BACK DISORDER 73 0.0045
272 CARDIAC FLUTTER 29 0.0045
273 MUSCULOSKELETAL STIFFNESS 393 0.0045
274 EAR DISCOMFORT 46 0.0045
275 KNEE OPERATION 44 0.0045
276 SPINAL OPERATION 55 0.0045
277 SKIN TIGHTNESS 21 0.0045
278 URINARY INCONTINENCE 132 0.0045
279 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 214 0.0045
280 MIGRAINE 424 0.0044
281 MACULAR DEGENERATION 53 0.0044
282 PERIORBITAL SWELLING 25 0.0044
283 NASOPHARYNGITIS 809 0.0044
284 TUMOUR MARKER INCREASED 21 0.0044
285 MUSCULOSKELETAL DISCOMFORT 75 0.0044
286 BLOOD POTASSIUM DECREASED 131 0.0044
287 ORAL HERPES 85 0.0044
288 CHEST DISCOMFORT 444 0.0043
289 ANKLE FRACTURE 67 0.0043
290 HYPOAESTHESIA 647 0.0043
291 FUNGAL INFECTION 144 0.0043
292 FLUSHING 439 0.0043
293 RALES 25 0.0043
294 SKIN WARM 25 0.0043
295 TASTE DISORDER 87 0.0043
296 BURSITIS 52 0.0043
297 DEFORMITY 40 0.0043
298 FAECES SOFT 31 0.0043
299 MUSCLE TIGHTNESS 69 0.0043
300 RESTLESS LEGS SYNDROME 77 0.0042
301 IRON DEFICIENCY ANAEMIA 39 0.0042
302 RESPIRATORY TRACT CONGESTION 67 0.0042
303 SKIN FISSURES 82 0.0042
304 JOINT STIFFNESS 110 0.0042
305 PRODUCTIVE COUGH 200 0.0042
306 WHEEZING 248 0.0042
307 POST PROCEDURAL INFECTION 34 0.0042
308 BOWEL MOVEMENT IRREGULARITY 32 0.0042
309 EAR INFECTION 111 0.0042
310 EYE IRRITATION 240 0.0042
311 DYSPEPSIA 410 0.0042
312 BLOOD ALBUMIN DECREASED 33 0.0042
313 FATIGUE 3234 0.0041
314 OROPHARYNGEAL PAIN 384 0.0041
315 MUSCULAR WEAKNESS 471 0.0041
316 SKIN DISORDER 138 0.0041
317 DRY THROAT 42 0.0041
318 GAIT DISTURBANCE 788 0.0041
319 BURNING SENSATION 288 0.0041
320 DYSGRAPHIA 27 0.0041
321 WRIST FRACTURE 49 0.0041
322 PERIPHERAL SWELLING 629 0.0041
323 DIVERTICULUM 29 0.0041
324 WHITE BLOOD CELL COUNT ABNORMAL 26 0.0041
325 UPPER LIMB FRACTURE 81 0.0041
326 FOOT FRACTURE 77 0.0041
327 GLUCOSE TOLERANCE IMPAIRED 24 0.0041
328 RHINORRHOEA 262 0.0040
329 LACRIMATION INCREASED 122 0.0040
330 BRONCHITIS 298 0.0040
331 DIZZINESS POSTURAL 39 0.0040
332 BREAST MASS 27 0.0040
333 INFUSION SITE EXTRAVASATION 25 0.0040
334 GAIT INABILITY 134 0.0040
335 MASS 56 0.0040
336 SCRATCH 42 0.0040
337 ARTHRITIS 313 0.0040
338 CANDIDA INFECTION 67 0.0040
339 UTERINE LEIOMYOMA 29 0.0040
340 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 206 0.0039
341 THERMAL BURN 28 0.0039
342 MEMORY IMPAIRMENT 540 0.0039
343 SPINAL PAIN 46 0.0039
344 HYSTERECTOMY 34 0.0039
345 GASTROINTESTINAL MOTILITY DISORDER 21 0.0039
346 THROAT IRRITATION 176 0.0039
347 PRODUCT LEAKAGE 22 0.0039
348 URINE ODOUR ABNORMAL 23 0.0039
349 GASTROINTESTINAL INFECTION 35 0.0039
350 GINGIVAL PAIN 31 0.0039
351 SKIN MASS 26 0.0039
352 TENDON RUPTURE 48 0.0039
353 COUGH 1086 0.0039
354 POOR QUALITY SLEEP 83 0.0039
355 HEART RATE IRREGULAR 87 0.0038
356 BACK PAIN 893 0.0038
357 COVID-19 674 0.0038
358 HAEMATOCRIT DECREASED 76 0.0038
359 PAIN OF SKIN 103 0.0038
360 PAIN IN JAW 108 0.0038
361 MOBILITY DECREASED 273 0.0038
362 PHOTOPSIA 24 0.0038
363 IMPAIRED DRIVING ABILITY 43 0.0038
364 BONE PAIN 221 0.0038
365 FEELING COLD 105 0.0038
366 PAIN IN EXTREMITY 1111 0.0038
367 SOMNOLENCE 759 0.0038
368 HEART RATE ABNORMAL 21 0.0038
369 ATRIAL FLUTTER 30 0.0038
370 HYPOTHYROIDISM 120 0.0038
371 LARGE INTESTINE POLYP 26 0.0037
372 RASH PAPULAR 84 0.0037
373 SKIN DISCOLOURATION 172 0.0037
374 FALL 1243 0.0037
375 ATRIAL FIBRILLATION 363 0.0037
376 WHITE BLOOD CELL COUNT DECREASED 404 0.0037
377 NASAL CONGESTION 219 0.0037
378 LIVER FUNCTION TEST INCREASED 80 0.0037
379 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 265 0.0037
380 CHRONIC KIDNEY DISEASE 283 0.0037
381 RESPIRATORY TRACT INFECTION 97 0.0037
382 LOCALISED INFECTION 90 0.0037
383 TOOTH FRACTURE 41 0.0037
384 INTENTIONAL DOSE OMISSION 106 0.0037
385 HYPOAESTHESIA ORAL 56 0.0037
386 PERIPHERAL COLDNESS 51 0.0037
387 NEUROPATHY PERIPHERAL 353 0.0037
388 BRUXISM 20 0.0037
389 APPLICATION SITE PRURITUS 84 0.0037
390 ERYTHEMA OF EYELID 20 0.0037
391 RASH PRURITIC 200 0.0037
392 PALPITATIONS 432 0.0037
393 PARAESTHESIA 580 0.0037
394 FEELING HOT 226 0.0037
395 IRRITABLE BOWEL SYNDROME 79 0.0037
396 GASTROINTESTINAL DISORDER 330 0.0037
397 PLATELET COUNT INCREASED 48 0.0037
398 DIVERTICULITIS 102 0.0037
399 PRODUCT DOSE OMISSION IN ERROR 104 0.0037
400 HEADACHE 2300 0.0037
401 NIGHT SWEATS 118 0.0037
402 LIMB INJURY 99 0.0036
403 PETECHIAE 38 0.0036
404 BLOOD PRESSURE SYSTOLIC INCREASED 71 0.0036
405 HAEMORRHOIDS 71 0.0036
406 GRIP STRENGTH DECREASED 32 0.0036
407 DEPRESSED MOOD 192 0.0036
408 HYPERSOMNIA 104 0.0036
409 BLOOD PRESSURE FLUCTUATION 87 0.0036
410 DECREASED ACTIVITY 39 0.0036
411 SWELLING 338 0.0036
412 APHTHOUS ULCER 28 0.0036
413 NODULE 47 0.0036
414 INTENTIONAL PRODUCT MISUSE 315 0.0036
415 ARTHRALGIA 1495 0.0036
416 INSOMNIA 957 0.0036
417 SPINAL DISORDER 34 0.0036
418 FRUSTRATION TOLERANCE DECREASED 29 0.0036
419 BLOOD THYROID STIMULATING HORMONE INCREASED 33 0.0036
420 FACIAL PAIN 32 0.0036
421 STOMATITIS 217 0.0036
422 PRURITUS 1375 0.0036
423 SKIN HAEMORRHAGE 53 0.0036
424 EYE SWELLING 133 0.0036
425 BLOOD PRESSURE ABNORMAL 71 0.0036
426 AGEUSIA 89 0.0036
427 KIDNEY INFECTION 70 0.0036
428 IMMUNE SYSTEM DISORDER 47 0.0036
429 OCULAR HYPERAEMIA 169 0.0036
430 VAGINAL DISCHARGE 36 0.0036
431 SKIN EXFOLIATION 300 0.0036
432 BLOOD SODIUM DECREASED 67 0.0036
433 MUSCLE ATROPHY 45 0.0035
434 IMPAIRED QUALITY OF LIFE 51 0.0035
435 THERAPY CESSATION 182 0.0035
436 BLOOD PRESSURE INCREASED 542 0.0035
437 HEAD INJURY 112 0.0035
438 TOOTHACHE 64 0.0035
439 MUSCULOSKELETAL PAIN 185 0.0035
440 RENAL CYST 28 0.0035
441 SENSITIVE SKIN 26 0.0035
442 ILLNESS 363 0.0035
443 SURGERY 206 0.0035
444 NEPHROLITHIASIS 161 0.0035
445 SPINAL COMPRESSION FRACTURE 29 0.0035
446 FAECES DISCOLOURED 76 0.0035
447 SCAR 60 0.0035
448 RIB FRACTURE 72 0.0035
449 APPLICATION SITE PAIN 77 0.0035
450 SENSORY DISTURBANCE 56 0.0035
451 THINKING ABNORMAL 65 0.0035
452 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
453 SENSORY LOSS 28 0.0035
454 EXERCISE TOLERANCE DECREASED 20 0.0035
455 BREAST PAIN 37 0.0035
456 RASH MACULAR 121 0.0035
457 TONGUE DISORDER 25 0.0035
458 HIP FRACTURE 111 0.0034
459 FORMICATION 24 0.0034
460 HEREDITARY ANGIOEDEMA 37 0.0034
461 DRY SKIN 460 0.0034
462 TINNITUS 158 0.0034
463 CLOSTRIDIUM DIFFICILE INFECTION 75 0.0034
464 DENTAL CARIES 38 0.0034
465 POST-TRAUMATIC STRESS DISORDER 23 0.0034
466 RETCHING 73 0.0034
467 VISION BLURRED 470 0.0034
468 TOOTH DISORDER 76 0.0034
469 ORAL CANDIDIASIS 45 0.0034
470 VERTIGO 208 0.0034
471 POSTOPERATIVE WOUND INFECTION 23 0.0034
472 INCREASED APPETITE 65 0.0034
473 DIPLOPIA 88 0.0034
474 DIZZINESS 1682 0.0034
475 ABDOMINAL DISCOMFORT 565 0.0034
476 FEELING ABNORMAL 806 0.0034
477 HERPES ZOSTER 193 0.0034
478 FEELING JITTERY 64 0.0034
479 THERAPY CHANGE 33 0.0034
480 HEART RATE INCREASED 332 0.0033
481 RHINITIS 27 0.0033
482 WEIGHT DECREASED 934 0.0033
483 WEIGHT INCREASED 749 0.0033
484 THROMBOSIS 269 0.0033
485 SUPRAVENTRICULAR TACHYCARDIA 32 0.0033
486 PRODUCT DISTRIBUTION ISSUE 31 0.0033
487 MUSCLE TWITCHING 77 0.0033
488 PELVIC FRACTURE 26 0.0033
489 PHARYNGITIS STREPTOCOCCAL 36 0.0033
490 GLAUCOMA 64 0.0033
491 JOINT SWELLING 401 0.0033
492 BREAST TENDERNESS 25 0.0033
493 DEPRESSION 755 0.0033
494 INCONTINENCE 35 0.0033
495 ARTHROPATHY 184 0.0033
496 MUSCULOSKELETAL DISORDER 63 0.0033
497 CATARACT 197 0.0033
498 IMPAIRED GASTRIC EMPTYING 45 0.0033
499 PRODUCT USE COMPLAINT 52 0.0033
500 TENDONITIS 51 0.0033
501 TREMOR 546 0.0033
502 FACIAL PARALYSIS 28 0.0033
503 OSTEOPOROSIS 135 0.0033
504 TOOTH INFECTION 43 0.0033
505 FLUID RETENTION 165 0.0032
506 TOOTH ABSCESS 33 0.0032
507 EPISTAXIS 242 0.0032
508 CELLULITIS 163 0.0032
509 WHITE BLOOD CELL COUNT INCREASED 124 0.0032
510 TRANSIENT ISCHAEMIC ATTACK 109 0.0032
511 DISTURBANCE IN ATTENTION 174 0.0032
512 BACK INJURY 35 0.0032
513 MALIGNANT MELANOMA 43 0.0032
514 MOVEMENT DISORDER 103 0.0032
515 INFLUENZA 357 0.0032
516 DECUBITUS ULCER 26 0.0032
517 VIRAL INFECTION 106 0.0032
518 DYSSTASIA 93 0.0032
519 SARS-COV-2 TEST POSITIVE 42 0.0032
520 POST PROCEDURAL COMPLICATION 61 0.0032
521 CONTRAINDICATED PRODUCT ADMINISTERED 96 0.0032
522 COGNITIVE DISORDER 148 0.0032
523 HYPOKINESIA 46 0.0032
524 DRUG INTOLERANCE 306 0.0032
525 BLOOD URINE PRESENT 60 0.0032
526 SPLENOMEGALY 37 0.0032
527 NASAL DISCOMFORT 25 0.0032
528 APHONIA 44 0.0031
529 CHILLS 369 0.0031
530 APHASIA 95 0.0031
531 SLUGGISHNESS 32 0.0031
532 DIARRHOEA 2023 0.0031
533 JOINT RANGE OF MOTION DECREASED 42 0.0031
534 MALNUTRITION 35 0.0031
535 EYE PRURITUS 105 0.0031
536 SKIN INFECTION 35 0.0031
537 CARDIAC DISORDER 291 0.0031
538 RESPIRATORY SYNCYTIAL VIRUS INFECTION 27 0.0031
539 PRODUCT LABEL ISSUE 21 0.0031
540 SPINAL FRACTURE 62 0.0031
541 FLANK PAIN 29 0.0031
542 DYSMENORRHOEA 41 0.0031
543 INJECTION SITE PRURITUS 207 0.0031
544 PHOTOSENSITIVITY REACTION 51 0.0031
545 SMALL INTESTINAL OBSTRUCTION 38 0.0031
546 DYSGEUSIA 229 0.0031
547 PHARYNGITIS 38 0.0031
548 BLOOD CREATININE INCREASED 200 0.0031
549 NERVE INJURY 34 0.0031
550 INJECTION SITE URTICARIA 75 0.0031
551 QUALITY OF LIFE DECREASED 41 0.0031
552 ASTHENIA 1148 0.0031
553 EATING DISORDER 65 0.0030
554 RESPIRATION ABNORMAL 21 0.0030
555 PNEUMONIA ASPIRATION 76 0.0030
556 PRODUCT SUBSTITUTION ISSUE 175 0.0030
557 HOSPICE CARE 30 0.0030
558 LYMPHOEDEMA 21 0.0030
559 PRODUCT DOSE OMISSION 198 0.0030
560 CRYING 110 0.0030
561 SKIN CANCER 65 0.0030
562 NAUSEA 2388 0.0030
563 DYSURIA 111 0.0030
564 BASAL CELL CARCINOMA 47 0.0030
565 MYALGIA 511 0.0030
566 HYPONATRAEMIA 169 0.0030
567 HERNIA 58 0.0030
568 POOR VENOUS ACCESS 31 0.0030
569 IMPAIRED WORK ABILITY 64 0.0030
570 BLINDNESS TRANSIENT 22 0.0030
571 ABDOMINAL PAIN UPPER 614 0.0030
572 THIRST 53 0.0030
573 CONDITION AGGRAVATED 899 0.0030
574 HEMIPARESIS 50 0.0029
575 PRODUCT PACKAGING ISSUE 28 0.0029
576 PAIN 1807 0.0029
577 PRODUCT DOSE OMISSION ISSUE 865 0.0029
578 BLISTER 165 0.0029
579 DECREASED APPETITE 681 0.0029
580 ELECTROCARDIOGRAM ABNORMAL 23 0.0029
581 ACCIDENT 35 0.0029
582 RENAL PAIN 31 0.0029
583 DRUG EFFECT LESS THAN EXPECTED 43 0.0029
584 HEPATIC STEATOSIS 54 0.0029
585 PSYCHOLOGICAL TRAUMA 25 0.0029
586 ANXIETY 824 0.0029
587 TOOTH EXTRACTION 36 0.0029
588 DRUG EFFECT INCOMPLETE 105 0.0029
589 EYE DISORDER 95 0.0029
590 VENTRICULAR EXTRASYSTOLES 30 0.0029
591 IMMUNODEFICIENCY 43 0.0029
592 HEART RATE DECREASED 101 0.0029
593 HUNGER 40 0.0029
594 LOWER LIMB FRACTURE 55 0.0029
595 PHARYNGEAL SWELLING 28 0.0029
596 DIABETES MELLITUS 218 0.0029
597 GALLBLADDER DISORDER 51 0.0029
598 LYMPHADENOPATHY 101 0.0029
599 BIPOLAR DISORDER 31 0.0028
600 MOTOR DYSFUNCTION 29 0.0028
601 INJECTION SITE BRUISING 227 0.0028
602 VISUAL IMPAIRMENT 352 0.0028
603 JOINT DISLOCATION 30 0.0028
604 RECALLED PRODUCT ADMINISTERED 27 0.0028
605 EYE INFLAMMATION 27 0.0028
606 PRURITUS GENERALISED 61 0.0028
607 GASTROINTESTINAL PAIN 31 0.0028
608 BEDRIDDEN 37 0.0028
609 NERVOUSNESS 147 0.0028
610 ABNORMAL FAECES 23 0.0028
611 SPEECH DISORDER 147 0.0028
612 HYPERSENSITIVITY 520 0.0028
613 AFFECTIVE DISORDER 22 0.0028
614 COVID-19 PNEUMONIA 33 0.0028
615 PAROSMIA 21 0.0028
616 GINGIVAL BLEEDING 38 0.0028
617 CHEST PAIN 514 0.0028
618 PARAESTHESIA ORAL 40 0.0028
619 ROAD TRAFFIC ACCIDENT 116 0.0028
620 IMPAIRED HEALING 91 0.0028
621 AUTOIMMUNE DISORDER 27 0.0028
622 SKIN SWELLING 24 0.0028
623 SNEEZING 62 0.0028
624 INFECTION 400 0.0028
625 HYPERTHYROIDISM 40 0.0028
626 RHEUMATOID ARTHRITIS 313 0.0028
627 APPLICATION SITE ERYTHEMA 72 0.0027
628 PROCEDURAL PAIN 76 0.0027
629 INFLUENZA LIKE ILLNESS 225 0.0027
630 SKIN IRRITATION 125 0.0027
631 HEPATIC ENZYME INCREASED 186 0.0027
632 OEDEMA PERIPHERAL 332 0.0027
633 FOOD ALLERGY 21 0.0027
634 IMMUNOSUPPRESSION 24 0.0027
635 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
636 FREQUENT BOWEL MOVEMENTS 73 0.0027
637 OVARIAN CYST 27 0.0027
638 NEOPLASM 31 0.0027
639 UNEVALUABLE EVENT 204 0.0027
640 PANIC ATTACK 98 0.0027
641 DYSPNOEA 1521 0.0027
642 PRODUCT CONTAINER ISSUE 23 0.0027
643 INJECTION SITE RASH 82 0.0027
644 INJECTION SITE ERYTHEMA 331 0.0027
645 COLD SWEAT 47 0.0027
646 ORAL DISCOMFORT 37 0.0027
647 CHROMATURIA 60 0.0027
648 FURUNCLE 21 0.0026
649 LIP DRY 24 0.0026
650 ADVERSE REACTION 35 0.0026
651 BONE DISORDER 48 0.0026
652 PRESYNCOPE 64 0.0026
653 DEHYDRATION 350 0.0026
654 HYPOPHAGIA 67 0.0026
655 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 48 0.0026
656 INABILITY TO AFFORD MEDICATION 26 0.0026
657 CHOKING 51 0.0026
658 AMNESIA 170 0.0026
659 LIP SWELLING 87 0.0026
660 KNEE ARTHROPLASTY 55 0.0026
661 THERAPEUTIC PRODUCT EFFECT DECREASED 117 0.0026
662 LABORATORY TEST ABNORMAL 77 0.0026
663 PULMONARY FIBROSIS 50 0.0026
664 HYPERTENSION 552 0.0026
665 DRUG PRESCRIBING ERROR 50 0.0026
666 ASTHMA 293 0.0026
667 ABDOMINAL PAIN 602 0.0026
668 ATELECTASIS 25 0.0026
669 LUNG DISORDER 126 0.0026
670 PULMONARY THROMBOSIS 28 0.0026
671 ERYTHEMA 527 0.0026
672 MOUTH ULCERATION 54 0.0026
673 OXYGEN SATURATION DECREASED 144 0.0026
674 INJECTION SITE DISCOLOURATION 32 0.0026
675 EYELID PTOSIS 26 0.0026
676 PRESCRIBED UNDERDOSE 51 0.0026
677 ESCHERICHIA INFECTION 21 0.0026
678 FEMUR FRACTURE 79 0.0025
679 DYSARTHRIA 96 0.0025
680 RASH 1106 0.0025
681 LOWER RESPIRATORY TRACT INFECTION 115 0.0025
682 DISCOMFORT 154 0.0025
683 EOSINOPHIL COUNT INCREASED 21 0.0025
684 PRODUCT USE ISSUE 473 0.0025
685 FEEDING DISORDER 51 0.0025
686 PRODUCT TASTE ABNORMAL 34 0.0025
687 HAEMOPTYSIS 70 0.0025
688 PNEUMONIA BACTERIAL 23 0.0025
689 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 451 0.0025
690 VAGINAL HAEMORRHAGE 108 0.0025
691 DERMATITIS 52 0.0025
692 INJECTION SITE SWELLING 190 0.0025
693 INFUSION RELATED REACTION 164 0.0025
694 WOUND INFECTION 27 0.0025
695 PLEURAL EFFUSION 150 0.0025
696 INJECTION SITE MASS 91 0.0025
697 STAPHYLOCOCCAL INFECTION 81 0.0025
698 BLOOD PRESSURE DECREASED 163 0.0025
699 DISORIENTATION 97 0.0024
700 THERAPEUTIC RESPONSE SHORTENED 81 0.0024
701 EUPHORIC MOOD 25 0.0024
702 ANAEMIA 465 0.0024
703 EXPIRED PRODUCT ADMINISTERED 81 0.0024
704 OEDEMA 132 0.0024
705 PULMONARY CONGESTION 32 0.0024
706 PELVIC PAIN 44 0.0024
707 HIP ARTHROPLASTY 37 0.0024
708 HAEMOGLOBIN DECREASED 248 0.0024
709 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 41 0.0024
710 GLOSSODYNIA 54 0.0024
711 PLATELET COUNT DECREASED 257 0.0024
712 URTICARIA 403 0.0024
713 SEPSIS 268 0.0024
714 WOUND 67 0.0024
715 ASPARTATE AMINOTRANSFERASE INCREASED 127 0.0024
716 PRODUCT USE IN UNAPPROVED INDICATION 589 0.0024
717 PARALYSIS 34 0.0024
718 PRODUCT ADMINISTRATION ERROR 48 0.0024
719 INTENTIONAL PRODUCT USE ISSUE 208 0.0024
720 DYSPHAGIA 225 0.0024
721 INFLAMMATION 122 0.0024
722 CHOLECYSTECTOMY 27 0.0024
723 HYPERHIDROSIS 304 0.0024
724 THERAPY INTERRUPTED 168 0.0023
725 ECZEMA 123 0.0023
726 SWELLING FACE 153 0.0023
727 PULMONARY EMBOLISM 223 0.0023
728 RENAL DISORDER 109 0.0023
729 ACUTE RESPIRATORY FAILURE 45 0.0023
730 TRANSAMINASES INCREASED 52 0.0023
731 ACNE 176 0.0023
732 CONJUNCTIVITIS 43 0.0023
733 CARDIAC MURMUR 20 0.0023
734 EMOTIONAL DISORDER 71 0.0023
735 SALIVARY HYPERSECRETION 23 0.0023
736 PSORIATIC ARTHROPATHY 93 0.0023
737 SKIN BURNING SENSATION 164 0.0023
738 PRODUCT PHYSICAL ISSUE 46 0.0023
739 ANOSMIA 33 0.0023
740 GASTRIC DISORDER 78 0.0023
741 INJECTION SITE NODULE 25 0.0023
742 APATHY 33 0.0023
743 INTESTINAL OBSTRUCTION 85 0.0023
744 NEPHROPATHY 21 0.0022
745 ANGER 76 0.0022
746 GASTRITIS 59 0.0022
747 INJECTION SITE INDURATION 29 0.0022
748 UNDERDOSE 163 0.0022
749 FEAR 60 0.0022
750 MOOD SWINGS 71 0.0022
751 RESTLESSNESS 81 0.0022
752 OBESITY 35 0.0022
753 VOMITING 1031 0.0022
754 INJECTION SITE WARMTH 45 0.0022
755 HYPERCALCAEMIA 27 0.0022
756 NEUTROPHIL COUNT DECREASED 89 0.0022
757 PNEUMONIA 705 0.0022
758 APPLICATION SITE IRRITATION 27 0.0022
759 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
760 LOSS OF CONSCIOUSNESS 277 0.0022
761 HYPOACUSIS 93 0.0022
762 RASH ERYTHEMATOUS 102 0.0021
763 ACTIVITIES OF DAILY LIVING IMPAIRED 42 0.0021
764 LIVER DISORDER 94 0.0021
765 SWOLLEN TONGUE 66 0.0021
766 INTRAOCULAR PRESSURE INCREASED 27 0.0021
767 OESOPHAGITIS 23 0.0021
768 ABNORMAL DREAMS 58 0.0021
769 INJECTION SITE DISCOMFORT 22 0.0021
770 DYSKINESIA 85 0.0021
771 MOOD ALTERED 57 0.0021
772 SKIN ULCER 54 0.0021
773 RENAL INJURY 62 0.0021
774 DERMATITIS ATOPIC 110 0.0021
775 SYSTEMIC LUPUS ERYTHEMATOSUS 74 0.0021
776 DRUG EFFECT DECREASED 112 0.0021
777 CHOLELITHIASIS 68 0.0021
778 COMPLICATION ASSOCIATED WITH DEVICE 30 0.0021
779 DEAFNESS 54 0.0021
780 LOCAL SWELLING 36 0.0021
781 GASTRIC ULCER 39 0.0020
782 SEIZURE 237 0.0020
783 LETHARGY 118 0.0020
784 CARDIOVASCULAR DISORDER 52 0.0020
785 PSORIASIS 267 0.0020
786 MALAISE 896 0.0020
787 APPLICATION SITE RASH 28 0.0020
788 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
789 GENERAL PHYSICAL HEALTH DETERIORATION 235 0.0020
790 EYE HAEMORRHAGE 27 0.0020
791 ABDOMINAL PAIN LOWER 51 0.0020
792 PULMONARY HYPERTENSION 42 0.0020
793 RESPIRATORY DISORDER 60 0.0020
794 PYREXIA 693 0.0020
795 DELUSION 31 0.0020
796 BLINDNESS UNILATERAL 28 0.0020
797 BLOOD TRIGLYCERIDES INCREASED 35 0.0020
798 INJECTION SITE PAIN 606 0.0020
799 INJECTION SITE REACTION 135 0.0020
800 THROAT TIGHTNESS 53 0.0020
801 WITHDRAWAL SYNDROME 82 0.0020
802 SUICIDAL IDEATION 178 0.0019
803 MENTAL IMPAIRMENT 47 0.0019
804 MENSTRUATION DELAYED 21 0.0019
805 NIGHTMARE 67 0.0019
806 MENORRHAGIA 38 0.0019
807 BLOOD UREA INCREASED 32 0.0019
808 ADVERSE DRUG REACTION 171 0.0019
809 COLITIS 72 0.0019
810 CORONARY ARTERY OCCLUSION 26 0.0019
811 ELECTROLYTE IMBALANCE 22 0.0019
812 POST PROCEDURAL HAEMORRHAGE 22 0.0019
813 PHARYNGEAL OEDEMA 29 0.0019
814 DRUG DOSE OMISSION 311 0.0019
815 IRRITABILITY 113 0.0019
816 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 103 0.0019
817 TYPE 2 DIABETES MELLITUS 63 0.0019
818 BLOOD CALCIUM DECREASED 21 0.0019
819 BONE LOSS 28 0.0019
820 PERICARDIAL EFFUSION 43 0.0019
821 HAEMATOMA 48 0.0019
822 RENAL IMPAIRMENT 155 0.0018
823 NEOPLASM PROGRESSION 64 0.0018
824 RECTAL HAEMORRHAGE 79 0.0018
825 HALLUCINATION 138 0.0018
826 ANKYLOSING SPONDYLITIS 24 0.0018
827 OFF LABEL USE 1592 0.0018
828 BODY TEMPERATURE INCREASED 37 0.0018
829 THERAPY NON-RESPONDER 81 0.0018
830 PULMONARY ARTERIAL HYPERTENSION 26 0.0018
831 ALANINE AMINOTRANSFERASE INCREASED 110 0.0018
832 CARDIOMEGALY 22 0.0018
833 RENAL FAILURE 237 0.0018
834 GASTROENTERITIS 26 0.0018
835 THERAPEUTIC RESPONSE DECREASED 108 0.0018
836 INCORRECT DOSE ADMINISTERED 405 0.0018
837 BLOOD ALKALINE PHOSPHATASE INCREASED 44 0.0018
838 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 359 0.0018
839 COLITIS ULCERATIVE 79 0.0018
840 OSTEOMYELITIS 32 0.0018
841 PRODUCT QUALITY ISSUE 240 0.0018
842 CARDIOMYOPATHY 26 0.0018
843 DEMENTIA 49 0.0018
844 PSYCHOMOTOR HYPERACTIVITY 29 0.0017
845 PARANOIA 30 0.0017
846 URINARY RETENTION 58 0.0017
847 HYPOTENSION 346 0.0017
848 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 40 0.0017
849 ERECTILE DYSFUNCTION 44 0.0017
850 INCORRECT DRUG ADMINISTRATION DURATION 48 0.0017
851 HYPOXIA 60 0.0017
852 PRODUCT PREPARATION ERROR 35 0.0017
853 SYNCOPE 170 0.0017
854 DEVICE RELATED INFECTION 26 0.0017
855 CONFUSIONAL STATE 271 0.0017
856 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
857 NEEDLE ISSUE 48 0.0016
858 COORDINATION ABNORMAL 23 0.0016
859 PRODUCT AVAILABILITY ISSUE 37 0.0016
860 BLOOD GLUCOSE DECREASED 77 0.0016
861 PRESCRIBED OVERDOSE 31 0.0016
862 DEVICE USE ISSUE 28 0.0016
863 DRUG INEFFECTIVE 2087 0.0016
864 DISEASE RECURRENCE 75 0.0016
865 BLOOD GLUCOSE ABNORMAL 29 0.0016
866 DISABILITY 31 0.0016
867 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
868 METRORRHAGIA 26 0.0015
869 DISEASE PROGRESSION 180 0.0015
870 HALLUCINATION, VISUAL 32 0.0015
871 HAEMORRHAGE 158 0.0015
872 DEEP VEIN THROMBOSIS 98 0.0015
873 EXTRA DOSE ADMINISTERED 61 0.0015
874 HAEMATOCHEZIA 82 0.0015
875 LYMPHOPENIA 21 0.0015
876 THERAPY PARTIAL RESPONDER 23 0.0015
877 RASH GENERALISED 38 0.0015
878 ILL-DEFINED DISORDER 89 0.0015
879 TACHYCARDIA 130 0.0015
880 DEVICE ISSUE 131 0.0015
881 MENSTRUATION IRREGULAR 39 0.0015
882 INJECTION SITE HAEMORRHAGE 116 0.0015
883 EXPOSURE VIA SKIN CONTACT 37 0.0014
884 ABASIA 35 0.0014
885 COMA 67 0.0014
886 PULMONARY OEDEMA 63 0.0014
887 CARDIAC FAILURE CONGESTIVE 113 0.0014
888 ECONOMIC PROBLEM 21 0.0014
889 PANCREATITIS 73 0.0014
890 ABSCESS 22 0.0014
891 MENTAL DISORDER 60 0.0014
892 ORTHOSTATIC HYPOTENSION 24 0.0014
893 ACUTE KIDNEY INJURY 209 0.0014
894 TREATMENT FAILURE 112 0.0014
895 HAEMATURIA 46 0.0013
896 BLOOD GLUCOSE INCREASED 253 0.0013
897 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 95 0.0013
898 HOSPITALISATION 205 0.0013
899 BLOOD BILIRUBIN INCREASED 36 0.0013
900 BLINDNESS 54 0.0013
901 AGITATION 97 0.0013
902 FRACTURE 25 0.0013
903 COAGULOPATHY 22 0.0013
904 NEOPLASM MALIGNANT 88 0.0013
905 DEVICE FAILURE 20 0.0013
906 DEVICE DISLOCATION 57 0.0013
907 PRODUCT PRESCRIBING ERROR 31 0.0013
908 VISUAL ACUITY REDUCED 43 0.0013
909 ANHEDONIA 34 0.0013
910 ANGINA PECTORIS 37 0.0013
911 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
912 INJURY 90 0.0013
913 MENTAL STATUS CHANGES 35 0.0013
914 AMENORRHOEA 22 0.0013
915 PALLOR 34 0.0012
916 PNEUMONITIS 34 0.0012
917 BRADYCARDIA 66 0.0012
918 TREATMENT NONCOMPLIANCE 68 0.0012
919 BREAST CANCER FEMALE 33 0.0012
920 HYPERGLYCAEMIA 44 0.0012
921 ADVERSE EVENT 110 0.0012
922 DEVICE MALFUNCTION 83 0.0012
923 PRODUCT ADHESION ISSUE 42 0.0012
924 HYPOKALAEMIA 54 0.0012
925 TOOTH LOSS 24 0.0012
926 DRUG ADMINISTRATION ERROR 35 0.0011
927 BREAST CANCER 106 0.0011
928 PLASMA CELL MYELOMA 44 0.0011
929 INTERNATIONAL NORMALISED RATIO INCREASED 32 0.0011
930 ARRHYTHMIA 53 0.0011
931 GASTROINTESTINAL HAEMORRHAGE 93 0.0011
932 SEDATION 29 0.0011
933 NERVOUS SYSTEM DISORDER 34 0.0011
934 OVERDOSE 229 0.0011
935 DRUG INTERACTION 166 0.0010
936 PRODUCT COMPLAINT 26 0.0010
937 ACUTE MYOCARDIAL INFARCTION 30 0.0010
938 PSYCHOTIC DISORDER 30 0.0010
939 MYOCARDIAL INFARCTION 174 0.0010
940 ANAPHYLACTIC REACTION 55 0.0010
941 CEREBROVASCULAR ACCIDENT 167 0.0010
942 EXPOSURE DURING PREGNANCY 61 0.0010
943 UNRESPONSIVE TO STIMULI 25 0.0010
944 ACCIDENTAL EXPOSURE TO PRODUCT 96 0.0009
945 LIVER FUNCTION TEST ABNORMAL 27 0.0009
946 FEBRILE NEUTROPENIA 61 0.0009
947 EMOTIONAL DISTRESS 111 0.0009
948 DEVICE BREAKAGE 37 0.0009
949 ABNORMAL BEHAVIOUR 36 0.0009
950 LEUKOPENIA 45 0.0009
951 DEVICE LEAKAGE 39 0.0009
952 ABORTION SPONTANEOUS 36 0.0009
953 HYPERKALAEMIA 31 0.0009
954 NEUTROPENIA 117 0.0009
955 OSTEONECROSIS 28 0.0009
956 MALIGNANT NEOPLASM PROGRESSION 87 0.0008
957 SEPTIC SHOCK 36 0.0008
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30 0.0008
959 C-REACTIVE PROTEIN INCREASED 30 0.0008
960 ACCIDENTAL OVERDOSE 30 0.0008
961 ANGIOEDEMA 36 0.0008
962 RESPIRATORY DISTRESS 22 0.0008
963 PRODUCT STORAGE ERROR 69 0.0008
964 BONE DENSITY DECREASED 24 0.0008
965 MATERNAL EXPOSURE DURING PREGNANCY 68 0.0008
966 HYPOGLYCAEMIA 37 0.0008
967 AGGRESSION 38 0.0008
968 PANCYTOPENIA 42 0.0008
969 THROMBOCYTOPENIA 84 0.0008
970 DELIRIUM 26 0.0007
971 RESPIRATORY FAILURE 53 0.0007
972 DEVICE EXPULSION 46 0.0007
973 LUNG NEOPLASM MALIGNANT 29 0.0007
974 CEREBRAL HAEMORRHAGE 25 0.0007
975 CARDIAC FAILURE 56 0.0007
976 DRUG WITHDRAWAL SYNDROME 59 0.0007
977 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 31 0.0007
978 EPILEPSY 20 0.0007
979 NO ADVERSE EVENT 115 0.0006
980 DEATH 541 0.0006
981 SUICIDE ATTEMPT 37 0.0006
982 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
983 FOETAL EXPOSURE DURING PREGNANCY 39 0.0005
984 INTERSTITIAL LUNG DISEASE 22 0.0005
985 CARDIAC ARREST 37 0.0004
986 DEVICE DIFFICULT TO USE 25 0.0004
987 DRUG DOSE OMISSION BY DEVICE 20 0.0003
988 TOXICITY TO VARIOUS AGENTS 35 0.0002
989 DRUG DEPENDENCE 27 0.0002